## Clear Cell RCC: Histopathologic Origin and Features ### Correct Answer Rationale **Key Point:** Clear cell RCC arises from the **proximal convoluted tubule (PCT)** epithelium, NOT from the collecting duct. The collecting duct origin is characteristic of a different renal malignancy — **chromophobe RCC** and **collecting duct carcinoma** — which are distinct entities. ### Pathologic Features of Clear Cell RCC | Feature | Detail | |---------|--------| | **Cell of origin** | Proximal convoluted tubule (PCT) epithelium | | **Cytoplasmic appearance** | Clear (lipid and glycogen rich) — lipid dissolves in routine processing | | **Genetic hallmark** | VHL (von Hippel-Lindau) gene loss on chromosome 3p | | **VHL consequence** | Loss of HIF-1α degradation → HIF accumulation → VEGF/PDGF upregulation | | **Growth pattern** | Expansile, well-demarcated, golden-yellow color (lipid content) | | **Sarcomatoid variant** | Rare, high-grade spindle cell pattern; poor prognosis | ### Why Collecting Duct Origin is Wrong **High-Yield:** Collecting duct carcinoma (Bellini duct carcinoma) is a **separate, aggressive renal malignancy** with: - Tubulopapillary or solid architecture - High-grade nuclei (Fuhrman 3–4) - Often presents at advanced stage - Much poorer prognosis than clear cell RCC - NOT associated with VHL loss (different molecular profile) ### Molecular Pathogenesis of Clear Cell RCC 1. **VHL inactivation** (80–90% of sporadic cases) → loss of 3p 2. **HIF-1α stabilization** (no proteasomal degradation) 3. **VEGF and PDGF upregulation** → angiogenesis 4. **Glucose and lipid accumulation** → clear cell phenotype **Clinical Pearl:** Patients with hereditary VHL syndrome have 40–50% lifetime risk of developing bilateral/multifocal clear cell RCC, often at younger age. [cite:Robbins 10e Ch 20]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.